Lipella Pharmaceuticals, Inc. Financial Overview
Lipella Pharmaceuticals, Inc.'s market cap is currently $840.99K. The company's EPS TTM is $-4.777; its P/E ratio is -0.08; Lipella Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.